Advertisement
Home Tags Food & Drug Administration

Tag: Food & Drug Administration

U.S. Food and Drug Administration approval of the Gardasil 9 human papillomavirus vaccine has been expanded to include people ages 27 through 45

FDA Approves HPV Vaccine for People Through Age 45

Updated vaccine designed to prevent cancers and disease caused by nine HPV types
Thousands of pages of documents were seized from the electronic cigarette maker JUUL by the U.S. Food and Drug Administration during a surprise inspection last week as part of the agency's investigation into the company's marketing practices.

FDA Seizes Documents From E-Cigarette Maker JUUL

JUUL has come into the FDA's crosshairs as the e-cigarette's popularity among teens is rising
Libtayo (cemiplimab-rwlc) injection has been approved by the U.S. Food and Drug Administration to treat metastatic cutaneous squamous cell carcinoma

FDA Approves New Treatment for Squamous Cell Carcinoma

Libtayo is the sixth FDA-approved immune checkpoint inhibitor targeting the PD-1 pathway
Arikayce (amikacin liposome inhalation suspension) has been approved by the U.S. Food and Drug Administration to treat lung disease caused by Mycobacterium avium complex bacteria among patients who do not respond to conventional therapies

FDA Approves New Drug for Antibiotic-Resistant Lung Disease

Arikayce approved to treat lung disease caused by Mycobacterium avium complex bacteria
The U.S. Food and Drug Administration on Tuesday launched a new ad campaign aimed at curbing rampant e-cigarette use among American teens.

FDA Ad Campaign Hopes to Halt E-Cigarette Use Among Teens

'The Real Cost' Youth E-Cigarette Prevention Campaign to target at-risk youth
The PK Papyrus Covered Coronary Stent System has been approved by the U.S. Food and Drug Administration to treat acute coronary artery perforations.

FDA Approves Device for Acute Coronary Artery Perforations

The PK Papyrus device is a balloon-expandable covered coronary stent and delivery system
Lumoxiti (moxetumomab pasudotox-tdfk) injection has been approved to treat certain instances of relapsed or refractory hairy cell leukemia

FDA Approves Novel Treatment for Hairy Cell Leukemia

Lumoxiti, a CD22-directed cytotoxin, approved for adults who have had at least two prior therapies
Calling the use of electronic cigarettes a burgeoning epidemic among teens

FDA Gets Tough on Juul, Other Electronic Cigarette Makers

More than 1,200 warning letters and fines have been sent to retailers and major e-cigarette manufacturers
Cassipa (buprenorphine and naloxone)

FDA Approves New Treatment for Opioid Dependence

The sublingual buprenorphine and naloxone combo should be part of a complete treatment plan
Four more online networks that operate 21 websites illegally selling potentially dangerous

FDA Warning Letters Target Illegal Online Sales of Opioids

Medications may be counterfeit, contaminated, expired, or otherwise unsafe